N-Ethylmaleimide

Identification

Name
N-Ethylmaleimide
Accession Number
DB02967  (EXPT02327)
Type
Small Molecule
Groups
Experimental
Description

A sulfhydryl reagent that is widely used in experimental biochemical studies. [PubChem]

Structure
Thumb
Synonyms
Not Available
Categories
UNII
O3C74ACM9V
CAS number
128-53-0
Weight
Average: 125.1253
Monoisotopic: 125.047678473
Chemical Formula
C6H7NO2
InChI Key
HDFGOPSGAURCEO-UHFFFAOYSA-N
InChI
InChI=1S/C6H7NO2/c1-2-7-5(8)3-4-6(7)9/h3-4H,2H2,1H3
IUPAC Name
1-ethyl-2,5-dihydro-1H-pyrrole-2,5-dione
SMILES
CCN1C(=O)C=CC1=O

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
TargetActionsOrganism
UGalectin-10Not AvailableHuman
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
KEGG Compound
C02441
PubChem Compound
4362
PubChem Substance
46509138
ChemSpider
4209
BindingDB
50220832
ChEBI
44485
ChEMBL
CHEMBL8211
HET
NEQ
Wikipedia
N-Ethylmaleimide
PDB Entries
1g86 / 2puo / 3v61 / 3v62 / 4ozt / 4us0

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)45.5 °CPhysProp
Predicted Properties
PropertyValueSource
Water Solubility254.0 mg/mLALOGPS
logP0.02ALOGPS
logP-0.055ChemAxon
logS0.31ALOGPS
pKa (Strongest Basic)-4.3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area37.38 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity33 m3·mol-1ChemAxon
Polarizability11.99 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+1.0
Blood Brain Barrier+0.999
Caco-2 permeable+0.6548
P-glycoprotein substrateNon-substrate0.7796
P-glycoprotein inhibitor INon-inhibitor0.8594
P-glycoprotein inhibitor IINon-inhibitor0.9469
Renal organic cation transporterNon-inhibitor0.7961
CYP450 2C9 substrateNon-substrate0.8078
CYP450 2D6 substrateNon-substrate0.8438
CYP450 3A4 substrateNon-substrate0.5974
CYP450 1A2 substrateNon-inhibitor0.9045
CYP450 2C9 inhibitorNon-inhibitor0.9071
CYP450 2D6 inhibitorNon-inhibitor0.9231
CYP450 2C19 inhibitorNon-inhibitor0.9026
CYP450 3A4 inhibitorNon-inhibitor0.9607
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8762
Ames testNon AMES toxic0.5396
CarcinogenicityNon-carcinogens0.8223
BiodegradationNot ready biodegradable0.5594
Rat acute toxicity3.5639 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9607
hERG inhibition (predictor II)Non-inhibitor0.9641
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MSGC-MSsplash10-03di-0900000000-c33b88171d7a7134d8ea
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - EI-BGC-MSsplash10-004i-9100000000-48f43555ac8c500a19ef
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-056u-6900000000-94013ce2ca6bdcffb4df
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0a7j-9400000000-53554a958dc4ae9f48a7
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0059-9000000000-fa6c358f580cb0f757de
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-014i-9000000000-e7b72b3c791bdf455d37

Taxonomy

Description
This compound belongs to the class of organic compounds known as maleimides. These are compounds containing a 2,5-pyrroledione moiety.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Pyrrolidines
Sub Class
Pyrrolidones
Direct Parent
Maleimides
Alternative Parents
N-substituted carboxylic acid imides / Pyrrolines / Dicarboximides / Azacyclic compounds / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
Substituents
Maleimide / Carboxylic acid imide, n-substituted / Carboxylic acid imide / Dicarboximide / Pyrroline / Azacycle / Carboxylic acid derivative / Organic oxygen compound / Organooxygen compound / Organonitrogen compound
Molecular Framework
Aliphatic heteromonocyclic compounds
External Descriptors
maleimides (CHEBI:44485) / a small molecule (N-ETHYLMALEIMIDE)

Targets

Kind
Protein
Organism
Human
Pharmacological action
Unknown
General Function
Cysteine-type endopeptidase activity involved in apoptotic process
Specific Function
Regulates immune responses through the recognition of cell-surface glycans. Essential for the anergy and suppressive function of CD25-positive regulatory T-cells (Treg).
Gene Name
CLC
Uniprot ID
Q05315
Uniprot Name
Galectin-10
Molecular Weight
16452.785 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423]

Drug created on June 13, 2005 07:24 / Updated on November 02, 2018 05:26